{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:53:04Z","timestamp":1790787184055,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1016\/j.clinthera.2006.03.006","type":"journal-article","created":{"date-parts":[[2006,6,7]],"date-time":"2006-06-07T17:13:22Z","timestamp":1149700402000},"page":"402-418","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["Efficacy and safety of mixed amphetamine salts extended release (adderall XR) in the management of oppositional defiant disorder with or without comorbid attention-deficit\/hyperactivity disorder in school-aged children and adolescents: A 4-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled, forced-dose-escalation study"],"prefix":"10.1016","volume":"28","author":[{"given":"Thomas J.","family":"Spencer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard B.","family":"Abikoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel F.","family":"Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Biederman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven R.","family":"Pliszka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Boellner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie C.","family":"Read","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Pratt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2006.03.006_bib1","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1097\/00004583-200012000-00007","article-title":"Oppositional defiant and conduct disorder: A review of the past 10 years, part I","volume":"39","author":"Loeber","year":"2000","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.clinthera.2006.03.006_bib2","series-title":"Children with oppositional defiant disorder. Facts for families. No. 72","author":"American Academy of Child & Adolescent Psychiatry","year":"2005"},{"key":"10.1016\/j.clinthera.2006.03.006_bib3","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2000"},{"key":"10.1016\/j.clinthera.2006.03.006_bib4","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1469-7610.2004.00250.x","article-title":"Conduct disorder and oppositional defiant disorder in a national sample: Developmental epidemiology","volume":"45","author":"Maughan","year":"2004","journal-title":"J Child Psychol Psychiatry"},{"key":"10.1016\/j.clinthera.2006.03.006_bib5","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/BF00916812","article-title":"Parenting stress among families of children with attention deficit hyperactivity disorder","volume":"20","author":"Anastopoulos","year":"1992","journal-title":"J Abnorm Child Psychol"},{"key":"10.1016\/j.clinthera.2006.03.006_bib6","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1176\/appi.ajp.159.7.1214","article-title":"Psychiatric comorbidity, family dysfunction, and social impairment in referred youth with oppositional defiant disorder","volume":"159","author":"Greene","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.clinthera.2006.03.006_bib7","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1023\/A:1005131131159","article-title":"Parenting and family stress treatment outcomes in attention deficit hyperactivity disorder (ADHD): An empirical analysis in the MTA study","volume":"28","author":"Wells","year":"2000","journal-title":"J Abnorm Child Psychol"},{"key":"10.1016\/j.clinthera.2006.03.006_bib8","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1001\/archpsyc.1987.01800130081010","article-title":"DSM-III disorders in preadolescent children. Prevalence in a large sample from the general population","volume":"44","author":"Anderson","year":"1987","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.clinthera.2006.03.006_bib9","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1001\/archpsyc.1988.01800360068010","article-title":"Estimates of the prevalence of childhood maladjustment in a community survey in Puerto Rico. The use of combined measures","volume":"45","author":"Bird","year":"1988","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.clinthera.2006.03.006_bib10","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/00004583-199303000-00018","article-title":"Patterns of diagnostic comorbidity in a community sample of children aged 9 through 16 years","volume":"32","author":"Bird","year":"1993","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.clinthera.2006.03.006_bib11","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/00004583-198911000-00010","article-title":"ADDH and conduct disorder: Degree of diagnostic overlap and dif ferences among correlates","volume":"28","author":"Szatmari","year":"1989","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.clinthera.2006.03.006_bib12","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1097\/00004583-199007000-00007","article-title":"The adolescent outcome of hyperactive children diag nosed by research criteria: I. An 8-year prospective follow-up study","volume":"29","author":"Barkley","year":"1990","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.clinthera.2006.03.006_bib13","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/00004583-198911000-00011","article-title":"The response of aggressive and nonaggres sive ADHD children to two doses of methylphenidate","volume":"28","author":"Barkley","year":"1989","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.clinthera.2006.03.006_bib14","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1023\/A:1015102812958","article-title":"The influence of ADHD-hyperactivity\/impulsivity symptoms on the development of oppositional defiant disorder symptoms in a 2-year longitudinal study","volume":"30","author":"Burns","year":"2002","journal-title":"J Abnorm Child Psychol"},{"key":"10.1016\/j.clinthera.2006.03.006_bib15","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1017\/S0012162203001282","article-title":"Attentiondeficit-hyperactivity disorder with and with out oppositional defiant disorder in 3- to 7-year-old children","volume":"45","author":"Kadesjo","year":"2003","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.clinthera.2006.03.006_bib16","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/00004583-200102000-00009","article-title":"ADHD comorbidity findings from the MTA study: Compar ing comorbid subgroups","volume":"40","author":"Jensen","year":"2001","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.clinthera.2006.03.006_bib17","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/01.chi.0000128791.10014.ac","article-title":"Symptomatic improvement in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment","volume":"43","author":"Abikoff","year":"2004","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.clinthera.2006.03.006_bib18","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/00004583-200503000-00008","article-title":"Atomoxetine treatment in children and adolescents with attention-deficit\/hyperactivity disorder and comorbid oppositional defiant disorder","volume":"44","author":"Newcorn","year":"2005","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.clinthera.2006.03.006_bib19","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/00004583-200102000-00011","article-title":"Clinical relevance of the primary findings of the MTA: Success rates based on severity of ADHD and ODD symptoms at the end of treatment","volume":"40","author":"Swanson","year":"2001","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.clinthera.2006.03.006_bib20","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"1987"},{"key":"10.1016\/j.clinthera.2006.03.006_bib21","series-title":"The CHQ: A User's Manual","author":"Landgraf","year":"1999"},{"key":"10.1016\/j.clinthera.2006.03.006_bib22","series-title":"ECDEU Assessment Manual for Psychopharmacology","first-page":"218","author":"Clinical Global Impressions (CGI)","year":"1976"},{"key":"10.1016\/j.clinthera.2006.03.006_bib23","series-title":"Coding Symbols for Thesaurus of Adverse Reaction Terms (COSTART)","year":"1995"},{"key":"10.1016\/j.clinthera.2006.03.006_bib24","first-page":"27","article-title":"Health-related quality of life and treatment satisfaction and preference in a community assessment study of extended-release mixed amphetamine salts for children with attention-deficit\/hyperactivity disorder","volume":"8","author":"Sallee","year":"2004","journal-title":"J Outcomes Res"},{"key":"10.1016\/j.clinthera.2006.03.006_bib25","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1046\/j.1440-1819.2002.01024.x","article-title":"Psychosocial problems in attentiondeficit hyperactivity disorder with oppositional defiant disorder","volume":"56","author":"Harada","year":"2002","journal-title":"Psychiatry Clin Neurosci"},{"key":"10.1016\/j.clinthera.2006.03.006_bib26","series-title":"Adderall XR","year":"2004"},{"key":"10.1016\/j.clinthera.2006.03.006_bib27","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/01.CHI.0000046863.56865.FE","article-title":"Analog classroom assessment of a once-daily mixed amphetamine formulation, SLI381 (Adderall XR), in children with AD HD","volume":"42","author":"McCracken","year":"2003","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.clinthera.2006.03.006_bib28","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1542\/peds.110.2.258","article-title":"A randomized, double-blind, placebo-controlled, parallel-group study of SLI381 (Adderall XR) in children with attentiondeficit\/hyperactivity disorder","volume":"110","author":"Biederman","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.clinthera.2006.03.006_bib29","series-title":"Poster presented at the 51st Annual Meeting of the American Academy of Child and Adolescent Psychiatry","article-title":"Safety and efficacy of MAS XR in adolescents with ADHD","author":"Grcevich","year":"2004"},{"key":"10.1016\/j.clinthera.2006.03.006_bib30","series-title":"Poster presented at: 50th Annual Meeting of the American Academy of Child and Adolescent Psychiatry","article-title":"Cardiovascular effects of extended-release mixed amphetamine salts","author":"Findling","year":"2003"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291806000713?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291806000713?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T08:47:31Z","timestamp":1758962851000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291806000713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["S0149291806000713"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2006.03.006","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2006,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of mixed amphetamine salts extended release (adderall XR) in the management of oppositional defiant disorder with or without comorbid attention-deficit\/hyperactivity disorder in school-aged children and adolescents: A 4-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled, forced-dose-escalation study","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2006.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}